Holen Sie sich die Stockscreener-App
0.6411
1.75%
-0.0114
Handel nachbörslich:
.65
0.0089
+1.39%
Schlusskurs vom Vortag:
$0.6525
Offen:
$0.6599
24-Stunden-Volumen:
8,922
Relative Volume:
0.24
Marktkapitalisierung:
$3.73M
Einnahmen:
$14.64M
Nettoeinkommen (Verlust:
$-13.74M
KGV:
-0.0882
EPS:
-7.27
Netto-Cashflow:
$-5.04M
1W Leistung:
-4.31%
1M Leistung:
+12.47%
6M Leistung:
-20.85%
1J Leistung:
-69.18%
1-Tages-Spanne:
$0.6411
$0.68
1-Wochen-Bereich:
$0.6211
$0.70
52-Wochen-Spanne:
$0.3611
$2.2599
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Vergleichen Sie NBY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.6411 | 3.90M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
NovaBay Pharmaceuticals Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com
What drives NovaBay Pharmaceuticals Inc. stock priceFree Technical Analysis Support - jammulinksnews.com
What analysts say about NovaBay Pharmaceuticals Inc. stockExceptional growth trajectory - jammulinksnews.com
Is NovaBay Pharmaceuticals Inc. a good long term investmentMarket-beating performance - printweek.in
When is the best time to buy NovaBay Pharmaceuticals Inc. stockFree Real-Time Market Predictions - beatles.ru
Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attentionMinimized Risk Maximum Return - Newser
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakout Setup Scanner - Newser
How NovaBay Pharmaceuticals Inc. stock performs during market volatilityReturn Optimized Trade Insights - Newser
StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World
NovaBay fails to gain shareholder approval for dissolution - MSN
NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - Defense World
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
NovaBay Pharmaceuticals approves liquidation plan By Investing.com - Investing.com Canada
NovaBay Pharmaceuticals approves liquidation plan - Investing.com
Poplar Point Capital Partners acquires $39,503 in NovaBay shares - Investing.com Australia
Poplar Point Capital Partners increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com South Africa
Poplar Point Capital increases stake in NovaBay Pharmaceuticals - Investing.com Australia
Massive Stock Acquisition: Poplar Point Capital Partners Bets Big on NovaBay Pharma! - TipRanks
Poplar Point Capital Partners acquires $29,857 in NovaBay shares - Investing.com Australia
Poplar Point Capital increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com India
Poplar Point Capital Partners acquires $39,503 in NovaBay shares By Investing.com - Investing.com India
Poplar Point Capital Partners acquires $29,857 in NovaBay shares By Investing.com - Investing.com Canada
Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions - Investing.com
Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions By Investing.com - Investing.com UK
NovaBay Pharmaceuticals sees $67,700 stock acquisition by Poplar Point Capital - Investing.com India
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):